American Vanguard Corp
American Vanguard Corp is a diversified agrochemical and specialty products company that develops, produces, and markets crop protection and animal health products, primarily in the United States and internationally. The company generates revenue through the sale of its products, including herbicides, insecticides, and fumigants, as well as through its closed delivery systems such as SmartBox Plus, Lock 'n Load, and EZ Load.
Business. American Vanguard Corp (NYSE: AVD) is a chemicals company operating within the Basic Materials sector. The firm is headquartered in the United States and is primarily listed on the New York Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
American Vanguard Corp (NYSE: AVD) is a chemicals company operating within the Basic Materials sector. The firm is headquartered in the United States and is primarily listed on the New York Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
### Capital Structure and Liquidity American Vanguard Corp has a market capitalization of $85.37 million and a price-to-book ratio of 1.59, indicating that the market values the company at a premium to its book value. The company's liquidity position is characterized as medium, with a current ratio of 2.32, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's operating cash flow was negative at -$35.44 million for the quarter, indicating a cash outflow from operations.
### Profitability and Returns The company's profitability is weak, with a net loss of -$4.15 million for the quarter and a return on equity of -2.19%. The return on assets is also negative at -0.62%, indicating that the company is not generating returns that exceed its cost of capital. The gross profit margin is 31.1%, which is in line with industry norms, but the operating margin is only 1.53%, reflecting high operating expenses relative to revenue.
### Segments and Geographic Exposure American Vanguard Corp operates in multiple geographic regions, with a significant portion of its revenue derived from the United States. The company's exposure to international markets is limited, with operations in countries such as Canada, Mexico, and other foreign jurisdictions. The company's revenue concentration in the U.S. may expose it to domestic economic and regulatory risks.
### Growth Trajectory The company's growth trajectory is uncertain, with a net loss in the most recent quarter and a negative operating cash flow. The company's ability to grow revenue is constrained by factors such as product liability claims, regulatory challenges, and competition from generic products. The company's debt structure, including a long-term debt of $264.38 million, may also limit its ability to invest in growth opportunities.
### Risk Factors The company faces several risk factors, including product and environmental liability, regulatory challenges, and the impact of economic conditions. The company's dependence on suppliers and global supply chain disruptions could also affect its operations. Additionally, the company's new debt structure and the ability to borrow under its credit facility are critical to its financial stability. The company has also identified material weaknesses in its internal controls over financial reporting, which could affect the accuracy of its financial statements.
### Recent Events Recent events include the adoption of new accounting guidance related to credit losses and the filing of a 10-K report that details the company's financial position and risk factors. The company has also been involved in legal proceedings related to product liability and environmental issues. The company's recent financial performance, including a net loss and negative operating cash flow, highlights the challenges it faces in maintaining profitability.
- American Vanguard Corp has a weak profitability profile, with a net loss and negative return on equity.
- The company's liquidity position is moderate, with a current ratio of 2.32, but it has a negative operating cash flow.
- The company's revenue is concentrated in the United States, which may expose it to domestic economic and regulatory risks.
- The company's growth is constrained by regulatory challenges, product liability claims, and competition from generic products.
Bull / Bear case
Generated · model-assistedAmerican Vanguard Corp ranks best-in-class for cash conversion within the Chemicals cohort, significantly outperforming the median.
The company maintains a current ratio of 1.77, indicating sufficient short-term liquidity to cover immediate obligations.
Gross profit improved to $147.6 million in FY2025, demonstrating resilience in core production margins despite operating losses.
American Vanguard Corp faces high credit risk, signaling significant concerns regarding its ability to meet debt obligations.
Net income plummeted to a $126.3 million loss in FY2025, reflecting a severe deterioration in overall profitability.
The debt-to-equity ratio of 1.41 places the company in the bottom quartile of its Chemicals cohort peers.
Operating income collapsed to a $101.6 million loss in FY2025, highlighting substantial inefficiencies in core business operations.
In focus — financials by report
Revenue $123.6M; Operating income $1.9M.
- ▍Revenue $123.6M
- ▍Operating income $1.9M
- ▍Net margin -3.4%
Revenue $364.4M; Operating income -$6.4M.
- ▍Revenue $364.4M
- ▍Operating income -$6.4M
- ▍Net margin -5.9%
Revenue $245.1M; Operating income $56.0k.
- ▍Revenue $245.1M
- ▍Operating income $56.0k
- ▍Net margin -3.8%
Revenue $515.1M; Operating income -$28.3M.
- ▍Revenue $515.1M
- ▍Operating income -$28.3M
- ▍Net margin -9.7%
Revenue $547.3M; Operating income -$101.6M.
- ▍Revenue $547.3M
- ▍Operating income -$101.6M
- ▍Net margin -23.1%
Revenue $547.3M; Operating income -$101.6M.
- ▍Revenue $547.3M
- ▍Operating income -$101.6M
- ▍Net margin -23.1%
Revenue $579.4M; Operating income $23.3M.
- ▍Revenue $579.4M
- ▍Operating income $23.3M
- ▍Net margin 1.3%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
- Source documents mention dilution or offering risk.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- SVP Operations & Supply Chain · Option to Buy → Common StockAcquired 20 000 @ $2,51grant · 2026-06-04
- CHRO · Option to Buy → Common StockAcquired 20 000 @ $2,51grant · 2026-06-04
- SVP Manufacturing · Option to Buy → Common StockAcquired 20 000 @ $2,51grant · 2026-06-04
- See Remarks · Option to Buy → Common StockAcquired 20 000 @ $2,51grant · 2026-06-04
- See Remarks · Option to Buy → Common StockAcquired 20 000 @ $2,51grant · 2026-06-04
- Director, CHIEF EXECUTIVE OFFICER · Option to Buy → Common StockAcquired 50 000 @ $2,51grant · 2026-06-04
- Chief Commercial Officer · Option to Buy → Common StockAcquired 20 000 @ $2,51grant · 2026-06-04
Actions
Ask Handelsavisen
- Market data
- Regulatory filings
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- AMERICAN VANGUARD CORP company facts · 2026-05-27
- AMERICAN VANGUARD CORP 10-Q 2026-05-06 · 2026-05-27
- AMERICAN VANGUARD CORP 10-K 2026-03-16 · 2026-05-27
- AMERICAN VANGUARD CORP 10-Q 2025-11-10 · 2026-05-27
- AMERICAN VANGUARD CORP 10-Q 2025-07-31 · 2026-05-27
Ownership & reference
Leadership
- Eric G. WintemuteChairman of the Board, Chief Executive Officer
Insider activity
- CHIEF EXECUTIVE OFFICER · Common StockOther 6 527 @ $2,36$15K · 2026-07-10
- Director · Common StockOther 31 872 · 2026-06-04
- Director · Common StockOther 31 872 · 2026-06-04
- Director · Common StockOther 31 872 · 2026-06-04
- Director · Common StockOther 31 872 · 2026-06-04
- Director · Common StockOther 31 872 · 2026-06-04
- Director · Common StockOther 31 872 · 2026-06-04
- CHIEF EXECUTIVE OFFICER · Common StockBought 5 000 @ $2,50$12K · 2026-06-03
- Director · Common StockBought 25 000 @ $2,70$68K · 2026-05-19
- Director · Common StockBought 20 000 @ $2,95$59K · 2026-05-13
- Director · Common StockBought 20 000 @ $2,92$58K · 2026-05-12
- CHIEF EXECUTIVE OFFICER · Common StockOther 4 790 @ $3,26$16K · 2026-01-29
- Director · Common StockOther 217 503 · 2025-11-26
- Director · Common StockOther 23 636 · 2025-11-26
- Director · Common StockOther 47 281 · 2025-11-26
- See Remarks · Common StockSold 6 000 @ $5,35$32K · 2025-09-04
- Director · Common StockOther 17 621 · 2025-08-07
- Director · Common StockOther 17 621 · 2025-08-07
- Director · Common StockOther 17 621 · 2025-08-07
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Total assets (YoY) (2025-12-31 vs 2024-12-31): -6.3%Derived (calculated)
- Net margin (FY 2025-12-31): -9.7%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 72.1%Derived (calculated)
- Gross margin (FY 2025-12-31): 28.6%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 18.1%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 61.1%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -640.2%Derived (calculated)
- Return on assets (FY 2025-12-31): -8.4%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): 60.0%Derived (calculated)
- Current ratio (FY 2025-12-31): 1.77xDerived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): -29.1%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): -5.9%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 22.6%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 0.1%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): -13.9%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 61.1%Derived (calculated)
- EPS (diluted) (annual): USD-PER-SHARES -2SEC XBRL filing
- Net income (annual): USD -49.88MSEC XBRL filing
- Interest expense (annual): USD 18.47MSEC XBRL filing
- Revenue (annual): USD 515.11MSEC XBRL filing
- Current assets (annual): USD 370.52MSEC XBRL filing
- Total assets (annual): USD 596.54MSEC XBRL filing
- Total liabilities (annual): USD 404.14MSEC XBRL filing
- Operating income (annual): USD -28.3MSEC XBRL filing